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Abstract: Perturbations of gene regulatory networks are essentially responsible for oncogenesis. Therefore, inferring the gene regulatory
networks is a key step to overcoming cancer. In this work, we propose a method for inferring directed gene regulatory networks based
on soft computing rules, which can identify important cause-effect regulatory relations of gene expression. First, we identify important
genes associated with a specific cancer (colon cancer) using a supervised learning approach. Next, we reconstruct the gene regulatory networks by inferring the regulatory relations among the identified genes, and their regulated relations by other genes within the
genome. We obtain two meaningful findings. One is that upregulated genes are regulated by more genes than downregulated ones, while
downregulated genes regulate more genes than upregulated ones. The other one is that tumor suppressors suppress tumor activators
and activate other tumor suppressors strongly, while tumor activators activate other tumor activators and suppress tumor suppressors
weakly, indicating the robustness of biological systems. These findings provide valuable insights into the pathogenesis of cancer.
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Background
Although many important genes responsible for the
genesis of various cancers have been discovered,
the molecular mechanisms underlying oncogenesis
remain unclear. Recently, the use of systems biology
approaches to understand the disease is generating
extensive interest.1–4 The advent of microarrays has
fueled investigations that use whole-genome expression profiles to understand cancer and to identify key
cancer-specific gene regulatory networks.5–11
The construction of gene regulatory networks
through microarrays is often called “reverse engineering.” There are two classes of reverse-engineering
algorithms: one identifying true physical interactions between regulatory proteins and their promoters, and the other identifying regulatory influences
between RNA transcripts.12 Here we limit our discussion to the second class: gene-to-gene interaction
networks. The interaction between two genes in a
gene network does not necessarily imply a physical
interaction, but can also refer to an indirect regulation via proteins, metabolites, and ncRNA that have
not been measured directly.13 In general, there are
two classes of gene-to-gene interaction networks:
undirected and directed. The popular algorithms for
reconstructing undirected networks are based on
similarity measures, such as Pearson correlation14,15
and mutual information,16–18 to name a few. One obvious deficiency of these methods is that the direction
of interaction is not specified. As a result, the causeeffect regulatory relations among genes cannot be
well characterized. In contrast, directed gene regulatory networks are capable of depicting the causeeffect regulatory relations, better providing insights
into biological systems than the co-expression relation. The oft-used methods for inferring directed
networks include Bayesian networks,19–23 Boolean networks,24–26 ordinary differential equations
(ODEs)27–33 et al. In the present study, we attempt
to develop a method for inferring gene regulatory
networks based on soft computing rules,34 by which
directed regulatory relations between gene pairs can
be induced. Although rule-based formalisms have
been used for inferring gene regulatory networks by
some investigators,35–39 the use of this kind of methods for inference of gene regulatory networks has
not yet been sufficiently explored.
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Most of the previous efforts toward the reconstruction of cancer-specific gene networks utilized
all gene expression data from microarrays to identify
the intricate interplay between genes, some of which
actually had nothing to do with the observed cancer
phenotype. As a result, gene interactions essentially
responsible for oncogenesis were difficult to detect.
To better discover authentic gene interactions relevant to cancer, in this work, we reconstruct cancerspecific gene regulatory networks by focusing on a
small number of relevant genes, each of which shows
good performance in distinguishing cancerous tissues
from normal ones. The main objective of this study is
to observe the roles played by high class-discrimination genes in the context of cancer-specific gene regulatory networks. We suspect that genes with good
classification ability have high centrality in the networks; that is, they are inclined to act as hub genes.
We use one colon-cancer-related microarray dataset
to validate our suspicion.

Results and Analysis
We use directed graphs to describe networks, in which
each node represents a gene and the presence of a
directed edge between two nodes indicates the existence of a regulatory relation between the connected
genes. We construct all network graphs using Cytoscape software.40 We aim to analyze two classes of
networks: one containing only the identified 18 genes
(refer to Materials and Methods) (Network Type 1),
and the other containing genes other than the 18 genes
(Network Type 2). Clearly, the former appears as a
subgraph of the latter for identical values (refer to
Materials and Methods).

Network type 1
For Network Type 1, we use red circle nodes to represent upregulated genes in tumor, and blue circle nodes
to represent downregulated genes in tumor. Thus, an
edge connecting two nodes with identical colors indicates a positive regulatory relation between the two
genes. In contrast, an edge connecting two nodes with
different colors indicates a negative regulatory relation between the two genes. When ] 1, no regulatory relation among the 18 genes is found, and when
]
0.95, three regulatory relations are identified
(Figure 1). They are TPM3, CSRP1, and S100A11
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Figure 1. Network Type 1 constructed under

= 0.95.

DARS

positively regulating SPARCL1, DES, and PCBD1,
respectively. The three regulatory relations are highly
reliable because the confidences of all decision rules
that infer them are no less than ] 0.95).34 The corresponding regulatory networks when
0.85 and
0.8 are shown in Figure 2 and Figure 3, respectively.
Clearly, if we denote the network graph derived from
by G( ), then, for 1  2, G( 2) must be a subgraph of G( 1); that is, as the value decreases, additional nodes and edges will be added to the former
graphs. Although the networks induced under greater
values are inclined to be more reliable, some important interactions are possibly missed. Table 1 lists the
connection degrees of all genes in the constructed
gene regulatory networks under different
values
and the average connection degrees. The indegrees
are presented in parentheses. From the table, we can
see that the connectivity of the majority of the nodes
is close to each other, and a small number of nodes
have relatively low connectivity. An interesting phenomenon is that the upregulated genes are regulated
by more other genes than the downregulated genes,
while the downregulated genes regulate more other
genes than the upregulated genes. This is particularly
evident under such mean values as 0.8 and 0.85.
Actually, when
0.8, the average number of genes
regulated by the downregulated genes is around nine
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Figure 2. Network Type 1 constructed under

= 0.85.

while the average number of genes regulating the
downregulated genes is around five. The P-value of
the t-test of the difference is approximately 0.0142,
indicating significance of the difference. In contrast,
when
0.8, the average number of genes regulated
by the upregulated genes is approximately four while
the average number of genes regulating the upregulated genes is approximately eight. The P-value of
the t-test is approximately 0.0177, also suggesting
that the difference is significant. When
0.85, the
P-values of the t-test for the downregulated genes
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Figure 3. Network Type 1 constructed under

= 0.80.

and the upregulated genes are 0.0004 and 0.0366,
respectively. In general, when equals 0.8 or 0.85,
we reach a more ideal balance between the identified
gene-interaction numbers and the reliability of the
identified interactions, relative to the other values.
Therefore, the above results revealing the difference
in regulatory direction for the two classes of cancerrelated genes are meaningful.
As we know, one common property of biological systems is robustness, which is a consequence of
natural selection and facilitates the evolvability of
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biological systems.41–50 Robustness enables biological
systems to withstand perturbations in the form of various diseases, including cancer. Although the mechanism underlying cancer remains unclear, accumulated
evidence has revealed that cancer is caused by genetic
perturbations.51–67 Therefore, biological systems may
have evolved to become robust to genetic perturbations to resist the occurrence of cancer.48–50 Here we
refer to upregulated genes in tumor as activators and to
downregulated genes as suppressors. We assume eight
regulatory patterns, as shown in Figure 4. Pattern 1
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Table 1. Connection degrees of identified genes in Network Type 1.
Gene/]

1

0.95

0.9

0.85

0.8

0.75

0.7

Average

DES
MYL9
CSRP1
ACTA2
SPARCL1
KCNMB1
Mgp
SLC2A4
myosin
TPM3
IL8
S100A11
HSPD1
HNRNPA1
DARS
SRPK1
IPL1
PCBD1

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1 (1)
0
1 (0)
0
1 (1)
0
0
0
0
1 (0)
0
1 (0)
0
0
0
0
0
1 (1)

2 (2)
2 (1)
2 (0)
4 (3)
4 (3)
6 (3)
4 (0)
1 (0)
0
4 (2)
1 (1)
2 (0)
0
2 (2)
0
0
0
2 (1)

10 (5)
9 (3)
10 (4)
9 (3)
10 (3)
13 (4)
11 (2)
5 (1)
3 (0)
13 (6)
3 (1)
14 (12)
3 (2)
5 (3)
3 (1)
1 (1)
13 (11)
14 (13)

14 (6)
12 (4)
20 (12)
12 (3)
15 (7)
14 (4)
16 (4)
12 (2)
7 (3)
18 (9)
6 (2)
16 (13)
7 (5)
17 (12)
7 (3)
5 (3)
14 (11)
17 (12)

17 (8)
24 (13)
23 (13)
18 (5)
20 (8)
29 (15)
26 (13)
24 (11)
15 (10)
22 (9)
21 (9)
21 (13)
14 (6)
22 (13)
13 (5)
10 (4)
20 (12)
21 (12)

22 (13)
27 (15)
27 (16)
27 (13)
27 (15)
29 (15)
27 (13)
25 (11)
19 (14)
22 (9)
22 (9)
26 (15)
15 (6)
27 (13)
18 (5)
15 (5)
25 (13)
26 (13)

9 (5)
12 (5)
12 (6)
10 (4)
11 (5)
13 (6)
12 (5)
10 (4)
6 (4)
11 (5)
8 (3)
11 (8)
6 (3)
10 (6)
6 (2)
4 (2)
10 (7)
12 (7)

The upregulated genes are formatted in boldface in table 1, 2 and 4.

represents one suppressor suppressing multi-activators;
Pattern 2 represents one suppressor activating multisuppressors; Pattern 3 represents one activator suppressing multi-suppressors; Pattern 4 represents one
activator activating multi-activators; Pattern 5 represents one suppressor being suppressed by multiactivators; Pattern 6 represents one suppressor being

S
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S

S1

A2…An
Pattern 5

S2…Sn

S1

S2…Sn

Pattern 3

S

A

S1

S2…Sn

Pattern 6

Figure 4. Eight regulatory patterns.
Abbreviations: S, suppressor; Si, the ith suppressor; A, activator; Ai, the ith activator, i
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activated by multi-suppressors; Pattern 7 represents
one activator being suppressed by multi-suppressors;
and Pattern 8 represents one activator being activated
by multi-activators. For robust biological systems, Patterns 1, 2, 6, and 7 should be strong while the others
should be weak; that is, the suppressors should function as the inhibitors of tumor as strongly as possible
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1, 2, …, n.
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by suppressing more tumor activators and activating
more tumor suppressors. In contrast, the activators
should function as the enhancers of tumor as weakly
as possible by suppressing less tumor suppressors and
activating less tumor activators. To prove the conjecture, for every identified gene, we calculate the value
of n, which is the number of genes regulating the gene
or being regulated by the gene under specific patterns
with
0.8. We use n to indicate the strength of the
patterns. The larger n is, the stronger the corresponding
pattern is. Table 2 presents the value of n, suggesting
that Patterns 1, 2, 6, and 7 are strong while Patterns
3, 4, 5, and 8 are relatively weak. Here we choose to
analyze the network constructed with
0.8 on the
basis of mainly two considerations: first, we obtain the
best classification accuracy when
0.8;34 second,
the sensitivity and specificity of the induced regulatory
relations could reach a better balance when
0.8
relative to the other values; that is, a substantial number of comparatively reliable gene regulatory relations
can be identified when
0.8.
In general, much of a cell’s activity is organized
as a network of interacting modules: sets of genes
coregulated to respond to different conditions.68
Modules constitute the ‘‘building blocks’’ of molecu-

Table 2. Values of n for eight regulatory patterns detected
when
0.8.
Pattern/

1

2

4
4
4
4
4
4
4
4
3
4

4
4
4
5
4
6
8
6
1
5

3

4

5

6

0
0
5
0
0
0
0
0
1
0

6
4
7
3
7
4
4
2
2
9

7

8

Gene
DES
MYL9
CSRP1
ACTA2
SPARCL1
KCNMB1
Mgp
SLC2A4
myosin
TPM3
IL8
S100A11
HSPD1
HNRNPA1
DARS
SRPK1
IPL1
PCBD1
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1
1
1
0
1
1
1
1

3
2
1
5
3
1
2
4

lar networks.49 The modular organization of molecular networks ensures functionality and robustness of
biological systems at some level. To explore the modularity of our colon-cancer-specific gene regulatory
networks, we use the Cytoscape plugin MCODE69 to
analyze the network constructed under
0.8. Two
significant modules are detected. They are presented
in Table 3. The first module is composed of 11 nodes
and 66 edges. Its clustering coefficient is 0.6, which
is rather high.70 The second module is composed
of three nodes and three edges, forming a feedforward loop, which is one consensus motif detected in
complex networks71 including transcriptional regulation networks.72 The three nodes represent three
upregulated genes, respectively. It possibly indicates
that the co-regulations of multiple activators are at
least partly, if not completely, responsible for the
occurrence of tumor. Further, we use the Cytoscape
plugin BiNGO73 to perform a GO (Gene Ontology)
based enrichment analysis of the two modules (see
Table S1 in the Supplementary Materials).

Network type 2
Network Type 2 exhibits the regulated relations of the
identified genes within the genome. We use red circle
nodes to represent identified upregulated genes, yellow circle nodes to represent identified downregulated
genes, and blue diamond nodes to represent other genes.
Table 3. Properties of two modules detected in network
Type 1 with
0.8.
Module/

1

2

PCBD1, TPM3, S100A11,
SPARCL1, HNRNPA1,
KCNMB1, ACTA2, IPL1,
Mgp, SLC2A4, CSRP1
11
66
0.6

HSPD1,
IL8,
DARS

Property
Genes
contained in
the module

1
10
0
8
0
0
10
10

1
3
5
4
3
3
1
2

Node number
Edge number
Clustering
coefficient
Upregulated
genes
Downregulated
genes

3
3
0.5

PCBD1, S100A11,
HNRNPA1, IPL1

HSPD1,
IL8,
DARS
TPM3, SPARCL1, KCNMB1, N/A
ACTA2, Mgp, SLC2A4,
CSRP1

“N/A” indicates that there is no related gene contained in the corresponding
modules.
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In addition, we label the nodes representing the identified
genes with their gene names, and the other nodes with
the attribute number of the corresponding genes in the
microarray decision table (the attribute numbers begin
from 0). The corresponding regulatory networks when
0.85 and 0.8 are shown in Figure 5 and Figure 6,
respectively. Similar to the situation in Network Type 1,
as the value decreases, more and more nodes and
edges will be added to the former graphs. Table 4 lists
the connection degrees of all identified genes in the gene
regulatory networks constructed under various values
and the average connection degrees. The indegrees are
presented in parentheses.
Regarding Network Type 2, we mainly focus on dissecting the situation that the identified genes are regulated
by the other genes. Table 4 shows that the upregulated
genes are regulated by more other genes than the downregulated genes. Especially, when equals 0.85 and 0.8,
there are respectively three and four upregulated genes
regulated by a large number of other genes so that they
form the hubs of extremely dense module subgraphs. To
quantitatively analyze the regulation difference between

the upregulated genes and the downregulated genes,
we respectively calculate the average numbers of genes
regulating all upregulated genes and all downregulated
genes under various values as well as their individual averages in whole, and use the t-test to evaluate the
significance of the difference. The results presented in
Table 5 suggest that the difference is significant when
value is 0.85 and 0.8 with a P-value threshold of 0.05.
Moreover, the average difference in whole is also significant. As noted above, the choice of analyzing the
regulatory relations induced under mean values is
relatively reasonable. Therefore, we can safely conclude
that the upregulated genes are more strongly regulated
by the other genes than the downregulated genes. It also
implies that the upregulated genes instead of the downregulated genes are inclined to form a high degree of
centrality in order to play key roles in cancer-specific
gene interaction networks. Similar discoveries were
made by other authors.8,74
Further, we use MCODE to analyze the network
constructed under
0.8. Three significant modules
are detected. They are presented in Table 6. It should

Figure 5. Network Type 2 constructed under  0.85.
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analysis of the three modules are presented in Table
S2 in the Supplementary Materials.

Discussion and Conclusions

Figure 6. Network Type 2 constructed under  0.8.

be noted that the actual clustering coefficients may
exceed the presented numbers because we do not take
into account the possibility that the non-identified genes
are regulated. The results of GO-based enrichment

The complicated molecular mechanism underlying
cancer lies in the perturbations of gene-interaction
networks at some level. Therefore, identifying cancer
genes and the pathways they control through the networks is a key step toward overcoming cancer. Generally speaking, directed gene regulatory networks
reflect the gene interactions more genuinely than
undirected gene co-expression networks in that the
principal cause-effect relations between genes can be
disclosed in directed gene regulatory networks. The
present work aims at inferring directed gene regulatory networks under specific disease conditions using
formalized rules, which facilitate the interpretability
of the inference model. We first identify the genes that
are relevant to a specific disease by supervised learning algorithms, and then infer the regulatory relations
among the identified genes and their regulated relations by all other genes. Our approach for inferring
regulation networks is based on soft computing rules.
The reliability of inferred regulation relations depends
on the confidence of corresponding rules, which is
governed by the controllable parameter . To ensure
sufficiently high reliabilities of the inferred relations, we set a high threshold for . When analyzing
the properties of inferred networks, we often select

Table 4. Connection degrees of identified genes in Network Type 2.
Gene/]

1

0.95

0.9

0.85

0.8

Average

DES
MYL9
CSRP1
ACTA2
SPARCL1
KCNMB1
Mgp
SLC2A4
myosin
TPM3
IL8
S100A11
HSPD1
HNRNPA1
DARS
SRPK1
IPL1
PCBD1

0
0
1 (1)
0
1 (1)
0
0
0
0
0
0
0
0
0
0
0
0
0

2 (2)
0
3 (2)
0
2 (2)
0
0
0
0
0
0
4 (3)
0
0
0
0
6 (6)
13 (13)

4 (3)
7 (6)
3 (2)
11 (10)
6 (5)
13 (10)
12 (8)
10 (9)
0
6 (4)
1 (1)
67 (64)
0
6 (6)
0
2 (2)
57 (57)
84 (83)

15 (10)
22 (17)
9 (5)
28 (22)
20 (13)
24 (15)
30 (21)
27 (23)
3 (1)
24 (18)
2 (1)
1369 (1367)
8 (7)
57 (55)
7 (5)
9 (9)
1772 (1770)
1569 (1568)

33 (25)
40 (33)
18 (13)
30 (22)
36 (28)
40 (29)
47 (36)
63 (54)
10 (6)
53 (45)
8 (4)
1401 (1399)
28 (27)
1752 (1747)
37 (33)
22 (21)
1787 (1785)
1595 (1591)

11 (8)
14 (11)
7 (5)
14 (11)
13 (10)
15 (9)
18 (13)
20 (17)
3 (1)
17 (13)
2 (1)
568 (567)
7 (7)
363 (362)
9 (8)
7 (6)
724 (724)
652 (651)
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Table 5. Contrast in regulatory circumstances of two groups of genes.
Statistics/]

0.95

0.9

0.85

0.8

Average

Average number of genes
regulating upregulated genes
Average number of genes
regulating downregulated genes
P-value (t-test)

2.75

26.625

597.75

825.875

290.75

0.6

5.7

14.5

29.1

9.8

0.1199

0.0679

0.0407

0.0178

0.0214

networks induced with a rational value of , which
contain substantial and reliable regulatory relations.
Our work results in several interesting findings
on colon-cancer-specific gene regulatory networks.
First, upregulated genes are regulated by more genes
than downregulated ones, while downregulated genes
regulate more genes than upregulated ones. Second,
tumor suppressors suppress tumor activators and activate as many other tumor suppressors as possible. In
contrast, tumor activators activate other tumor activators and suppress as few tumor suppressors as possible. This result reflects the robustness of biological
systems at some level. For the first finding, we have
presented some previous research reports which hold
the similar notion. For the second finding, we have
given statistical analysis pertinently. Therefore, to a
certain extent, the biological results derived based
on our assumption are reasonable and relevant. Of
course, the reliability of these conclusions needs to
be verified with more experimental data.
In terms of our inference rules, A B while A B
imply a directed relationship of A toward B. If both A and

B are concerned with gene expressions, this relationship
can be taken as one kind of regulation relationship rather
than simple correlation relationship between gene pairs.
In effect, decision rules have been admittedly applied to
mining cause-effect relations in machine learning and
data mining community. Specifically, the decision logic
language (DLL) introduced by Pawlak75 gives the formal definition of decision rules, indicative of the causeeffect relationship derived in decision rules.34
Further, according to our inference logic, the fact that
from the up-regulation of gene A, we can infer the upregulation of gene B, and from the down-regulation of
A, we can infer the down-regulation of B (but not the
reverse) means that the expression of gene A can determine the expression of gene B (while the expression of
gene B cannot determine the expression of gene A). From
this correlation, we can infer the regulation direction,
indicating that A regulates B. Thus, the inferred gene-togene interaction networks are directed gene regulatory
networks more than simple co-expression networks. It
should be noted that our directed gene regulatory relations refer to one kind of wide interactions between gene

Table 6. Properties of three modules detected in Network Type 2 with
Module/]

0.8.

1

2

3

PCBD1, S100A11, Mgp, SPARCL1,
SLC2A4, IPL1, HNRNPA1, TPM3, BCL3,
MAOB, SDC2, SRF, PRDX6, VIP, CALD1,
DELTA-CRYSTALLIN ENHANCER
BINDING FACTOR
16
88
0.37
PCBD1, S100A11, IPL1,
HNRNPA1, SDC2
Mgp, SPARCL1, SLC2A4, TPM3, SRF,
BCL3, MAOB, PRDX6, VIP, CALD1,
DELTA-CRYSTALLIN ENHANCER
BINDING FACTOR

DES, KCNMB1,
MYL9, ACTA2,
CEBPD, CCND3,
SRF

HSPD1, SRPK1,
HNRNPM

7
14
0.33
N/A

3
4
0.25
HSPD1, SRPK1,
HNRNPM
N/A

Property
Genes contained in
the module

Nodes number
Edges number
Clustering coefficient
Upregulated genes
Downregulated genes

DES, MYL9,
ACTA2, KCNMB1,
CCND3, CEBPD,
SRF

“N/A” indicates that there is no related gene contained in the corresponding modules.
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pairs such as the upstream and downstream relations in
a signaling pathway, not necessarily implying physical
interactions or direct regulations between them. Certainly, we agree that the use of steady gene expression
data gives rise to limitations in inference of directed gene
regulatory networks, and if perturbation data or timeseries data are used in network inference, the inferred
pair-wise regulation relations could be more convincing.
This is our next study objective.
Our method belongs to the rule-based network
inference. In this point, it is similar to decision tree.
However, essentially differing from decision tree,
our gene regulatory relations are induced by decision
rules, which are based on the subset (set inclusion)
relations and well formalized in the DLL. In addition,
although our soft computing rule resembles to probabilistic score thereby demonstrating the reliability of
our inference rules, soft computing approach is essentially different from probability theory in that soft
computing exploits the given tolerance of imprecision,
partial truth, and uncertainty for a particular problem,
making it to model and analyze complex systems in a
more flexible and robust manner and finally give useful answers. Soft computing has the major advantages
in inductive reasoning and uncertain reasoning.

Materials and Methods
Dataset
The microarray dataset we study is the Colon Cancer
dataset,76 which contains 62 samples collected from
colon cancer patients. Among them, 40 tumor biopsies
are from tumors and 22 normal biopsies are from healthy
parts of the colons of the same patients. Each sample
is described by 2000 genes. In our previous work,34 we
identified 21 genes or ESTs, each of which possesses
fairly good classification performance. In this work,
we choose to analyze 18 definitely annotated genes

out of them, which include DES, MYL9, CSRP1, IL8,
S100A11, ACTA2, HSPD1, HNRNPA1, SPARCL1,
DARS, KCNMB1, MGP, SLC2A4, myosin, TPM3,
SRPK1, IPL1, and PCBD1.
The microarray dataset studied by our methodology
is organized in the form of decision tables. One decision
table can be represented by S (U, A C D), where
U is the set of samples, C the condition attribute set, and
D the decision attribute set. Table 7 is the decision table
representing the Colon Cancer microarray dataset. In
the decision table, there are 62 samples, 2000 condition
attributes, and one decision attribute. Every sample is
assigned to one class label: Tumor or Normal.
In the decision table, we define a function Ia that
maps a member (sample) of U to the value of the
member on the attribute a (a A), and an equivalence
relation R(A’) induced by the attribute subset A’ A,
as follows: for x, y U, xR(A’)y if and only if Ia(x)
Ia(y) for each a A’.34

Depended Degree, Decision Rules,
and Learning Algorithm
In,34 we identify one high class-discrimination feature
based on the depended degree, which is a generalization of the depended degree proposed in rough sets.77
Here we restate the concept briefly. The ] depended
degree of condition subset P by decision attribute set
D is defined by:
P

where 0

(D, ) =

|POS P (D, )| ,
|U |

] 1,

|POS P (D,

)| = |

pos(P, X , )|
)
X U /R(D)

}.
and pos ( P, X , ) = {Y U/R ( P ) | | Y X | | Y |
Here |*| denotes the size of set * and U/R(•) denotes the

Table 7. Colon cancer microarray dataset decision table.
Sample
1
2
…
61
62
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Condition attribute (gene)
…
Gene 1
Gene 249

…

Gene 2000

Class label

8589.4163
9164.2537
…
6234.6225
7472.01

…
…
…
…
…

28.70125
16.77375
…
23.265
39.63125

Tumor
Normal
…
Tumor
Normal

…
…
…
…
…

500.425
335.69
…
272.92875
2699.1925

Decision attribute (class)
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Table 8. Discretized colon cancer microarray dataset decision table.
Sample
1
2
…
61
62

Condition attribute (gene)
…
Gene 1
Gene 249

…

Gene 2000

Class label

‘All’
‘All’
…
‘All’
‘All’

…
…
…
…
…

‘All’
‘All’
…
‘All’
‘All’

Tumor
Normal
…
Tumor
Normal

…
…
…
…
…

‘(-inf-1696.2275)’
‘(1696.2275-inf)’
…
‘(-inf-1696.2275)’
‘(1696.2275-inf)’

Decision attribute (class)

“ ‘All’ ” indicates that one gene has the same value in all samples; “ ‘(-inf-x)’ ” indicates “

set of equivalence classes induced by the equivalence
relation R(•). The depended degree is a specific case of
the ] depended degree when ] 1.34
In,34 we create classifiers based on decision rules. One
decision rule in the form of “A B” indicates that “if
A, then B,” where A is the description of condition attributes and B, the description of decision attributes. The
confidence of a decision rule A B is defined as follows:
confidence(A

B) =

support (A B)
,
support (A)

where support(A) denotes the proportion of samples
satisfying A and support(A B) denotes the proportion of samples satisfying A and B simultaneously.
The confidence of a decision rule indicates the reliability of the rule.
In,34 for each determined ] value, we select only
the genes with cP(D,])  1 to build decision rules.
Suppose g is one of the selected genes and U is the
sample set. U/R(g) {c1(g), c2(g), …, cn(g)} represents
the set of the equivalence class of samples induced
by R(g). Two samples, s1 and s2, belong to the same
equivalence class of U/R(g) if and only if they have
the same value on g. In addition, we represent the set
of the equivalence class of samples induced by R(D)
as U/R(D) {d1(D), d2(D), …, dm(D)}, where D is the
decision attribute. Likewise, two samples, s1 and s2,

x”; “ ‘(x-inf)’ ” indicates “ x”.

belong to the same equivalence class of U/R(D) if and
only if they have the same value on D. For each ci(g)
(i 1, 2, …, n), if there exists some value of dj(D)
( j {1, 2, …, m}), satisfying ci( g) dj(D) in light of
the depended degree or |ci( g) dj(D)|/|ci(g)| ] in
light of the ] depended degree, we then generate the
following decision rule: A(ci(g))
B(dj(D)), where
A(ci(g)) is the formula describing the sample set ci(g)
by the g value, and B(dj(D)) is the formula describing
the sample set dj(D) by the class value. We ensure
sufficient reliability of the derived decision rules by
setting a high threshold for the ] value.
Because our method is suitable for handling discrete data, we discretize the original microarray
dataset decision table before carrying out the learning algorithm. We use the entropy-based discretization method78 and implement the discretization in the
Weka package.79 Table 8 is the discretized decision
table of Table 7. From Table 8, we can infer that Gene
1 and Gene 2000 cannot distinguish different classes,
while Gene 249 can distinguish different classes by
two decision rules: if the expression level of Gene
249 in one sample is not greater than 1696.2275,
then the sample is Tumor (89% confidence); otherwise, the sample is Normal (86% confidence); that is,
if Gene 249 is downregulated in one sample, then the
sample is Tumor; if Gene 249 is upregulated in one
sample, then the sample is Normal. Using the two

Table 9. Colon cancer microarray dataset decision table.
Sample
1
2
…
61
62

Condition attribute (gene)
…
Gene 1
Gene 245

…

Gene 2000

Gene 249

8589.4163
9164.2537
…
6234.6225
7472.01

…
…
…
…
…

28.70125
16.77375
…
23.265
39.63125

Downregulation
Upregulation
…
Downregulation
Upregulation

…
…
…
…
…

Gene Regulation and Systems Biology 2010:4

475.27885
1648.4596
…
191.33846
1240.5846

Decision attribute (class)
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Table 10. Discretized decision table of Table 9.
Sample
1
2
…
61
62

Condition attribute (gene)
…
Gene 1
Gene 245
‘All’
‘All’
…
‘All’
‘All’

…
…
…
…
…

‘(-inf-1048.3779)’
‘(1048.3779-inf)’
…
‘(-inf-1048.3779)’
‘(1048.3779-inf)’

rules, we achieve 84% leave-one-out cross-validation (LOOCV) accuracy. Among the aforementioned
18 genes, DES, MYL9, CSRP1, ACTA2, SPARCL1,
KCNMB1, MGP, SLC2A4, myosin, and TPM3
belong to downregulated genes in Tumor, while IL8,
S100A11, HSPD1, HNRNPA1, DARS, SRPK1,
IPL1, and PCBD1 belong to upregulated genes in
Tumor.

Inference of gene regulatory network
If the decision attribute is one gene instead of the
class, then we can induce the decision rules inferring regulatory relations among distinct genes. For
example, if we substitute “Gene 249” for “Class
label” in Table 7, that is, we regard Gene 249 as the
decision attribute, which has two distinct values:
upregulation and downregulation, we obtain
Table 9.
Likewise, we implement the discretization of
Table 9 to obtain Table 10. Applying the same learning algorithm to Table 10, we can induce the decision
rules linking Gene 245 to Gene 249: if the expression level of Gene 245 in one sample is not greater
than 1048.3779, then Gene 249 is downregulated
(96% confidence); otherwise, Gene 249 is upregulated (100% confidence). In other words, if Gene
245 is downregulated, then Gene 249 is downregulated; if Gene 245 is upregulated, then Gene 249 is
upregulated. They are not necessarily true in reverse.
Therefore, we infer a directed regulatory relation of
Gene 245 to Gene 249, which is positive.
In the same way, we regard each of the 18 identified genes as the decision attribute in turn, and infer
the regulatory relations that the other genes exert on
them. We infer those networks with value equal to
1, 0.95, 0.9, 0.85, 0.8, 0.75, or 0.7.

30

Decision attribute (class)
…

Gene 2000

Gene 249

…
…
…

‘All’
‘All’
…
‘All’
‘All’

Downregulation
Upregulation
…
Downregulation
Upregulation

…
…
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Supplemental Materials
Table S1. GO terms significantly enriched with two modules in Network Type 1 (

0.8).

GO/Module

Category

GO-ID

Description

P-value

1

Molecular function

48306

0.00003

2

Biological process

42221

Molecular function

5524
32559

Calcium-dependent
protein binding
Response to chemical
stimulus
ATP binding
Adenyl ribonucleotide
binding
Adenyl nucleotide binding

30554
GO terms shared by more than one gene with P

0.005
0.02
0.02
0.02

0.05 are identified.

Table S2. GO terms significantly enriched with three modules in Network Type 2 (

0.8).

GO/Module

Category

GO-ID

Description

P-value

1

Biological process

51239

Regulation of multicellular
organismal process
Nuclear import
Regulation of binding
Positive regulation of
transcription
Positive regulation of gene
expression
Positive regulation of
nucleobase, nucleoside,
nucleotide and nucleic acid
metabolic process
Positive regulation of
macromolecule biosynthetic
process
Positive regulation of
biosynthetic process
Nucleocytoplasmic transport
Nuclear transport
Positive regulation of
macromolecule metabolic
process
Calcium-dependent
protein binding
Contractile fiber part
Contractile fiber
RNA splicing
RNA processing
Nucleotide binding

0.001

51170
51098
45941
10628
45935

10557
9891
6913
51169
10604
Molecular function

48306

2

Cellular component

3

Biological process

44449
43292
6395
6394
166

Molecular function
GO terms shared by more than one gene with P
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0.002
0.003
0.003
0.003
0.003

0.004
0.005
0.005
0.005
0.006
0.00007
0.0004
0.0004
0.001
0.003
0.002

0.05 are identified.
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